News

GSK plans to purchase an experimental drug for the liver disease MASH from Boston Pharmaceuticals for $1.2 billion upfront.
New research reveals that semaglutide significantly improves liver health in MASH patients. A new study published in the New ...
Discover how metabolic dysfunction-associated steatohepatitis (MASH) damages your liver, its connection to common health ...
You might not think much about what makes a liver healthy or unhealthy. And when your liver starts to become unhealthy, you ...
Aroosha Sarrafi tells Health her story of getting diagnosed with metabolic dysfunction-associated steatohepatitis (MASH), a ...
On a quest to expand the eligible patient pool for its fast-growing liver disease drug Rezdiffra, Madrigal Pharmaceuticals ...
GLP-1 RA helped resolution of steatohepatitis without worsening fibrosis and reduced liver fibrosis without worsening ...
This local sensation mashes up pop and rock hits with a full brass section, turning every show into a high-energy singalong.
Weekly 2.4 mg semaglutide was linked to improved liver histology results but did not significantly reduce body pain compared ...
Once-monthly efimosfermin alfa prescribed for metabolic dysfunction–associated steatohepatitis with F2 and F3 fibrosis ...
Some have been standing there for over an hour. The band that’s worth the wait? Brass Mash. Aptly named, Brass Mash is a local SLO County brass-instrument-based mash-up band. “It’s not a ...